Ward W H, Holdgate G A, Rowsell S, McLean E G, Pauptit R A, Clayton E, Nichols W W, Colls J G, Minshull C A, Jude D A, Mistry A, Timms D, Camble R, Hales N J, Britton C J, Taylor I W
AstraZeneca, Mereside, Macclesfield, Cheshire, U.K.
Biochemistry. 1999 Sep 21;38(38):12514-25. doi: 10.1021/bi9907779.
Triclosan is used widely as an antibacterial agent in dermatological products, mouthwashes, and toothpastes. Recent studies imply that antibacterial activity results from binding to enoyl (acyl carrier protein) reductase (EACPR, EC 1.3.1.9). We first recognized the ability of triclosan to inhibit EACPR from Escherichia coli in a high throughput screen where the enzyme and test compound were preincubated with NAD(+), which is a product of the reaction. The concentration of triclosan required for 50% inhibition approximates to 50% of the enzyme concentration, indicating that the free compound is depleted by binding to EACPR. With no preincubation or added NAD(+), the degree of inhibition by 150 nM triclosan increases gradually over several minutes. The onset of inhibition is more rapid when NAD(+) is added. Gel filtration and mass spectrometry show that inhibition by triclosan is reversible. Steady-state assays were designed to avoid depletion of free inhibitor and changes in the degree of inhibition. The results suggest that triclosan binds to E-NAD(+) complex, with a dissociation constant around 20-40 pM. Triclosan follows competitive kinetics with respect to NADH, giving an inhibition constant of 38 pM at zero NADH and saturating NAD(+). Uncompetitive kinetics are observed when NAD(+) is varied, giving an inhibition constant of 22 pM at saturating NAD(+). By following regain of catalytic activity after dilution of EACPR that had been preincubated with triclosan and NAD(+), the rate constant for dissociation of the inhibitor (k(off)) is measured as 1.9 x 10(-4) s(-1). The association rate constant (k(on)) is estimated as 2.6 x 10(7) s(-1) M(-1) by monitoring the onset of inhibition during assays started by addition of EACPR. As expected, the ratio k(off)/k(on) = 7.1 pM is similar to the inhibition constants from the steady-state studies. The crystal structure of E. coli EACPR in a complex with coenzyme and triclosan has been determined at 1.9 A resolution, showing that this compound binds in a similar site to the diazaborine inhibitors. The high affinity of triclosan appears to be due to structural similarity to a tightly bound intermediate in catalysis.
三氯生作为一种抗菌剂,被广泛应用于皮肤科产品、漱口水和牙膏中。最近的研究表明,其抗菌活性源于与烯酰(酰基载体蛋白)还原酶(EACPR,EC 1.3.1.9)的结合。在一项高通量筛选中,我们首次认识到三氯生抑制大肠杆菌EACPR的能力,在该筛选中,酶和测试化合物与反应产物NAD(+) 预先孵育。50%抑制所需的三氯生浓度约为酶浓度的50%,这表明游离化合物因与EACPR结合而耗尽。在没有预先孵育或添加NAD(+) 的情况下,150 nM三氯生的抑制程度在几分钟内逐渐增加。添加NAD(+) 时,抑制的起始更快。凝胶过滤和质谱分析表明,三氯生的抑制作用是可逆的。设计稳态测定以避免游离抑制剂的耗尽和抑制程度的变化。结果表明,三氯生与E-NAD(+) 复合物结合,解离常数约为20 - 40 pM。三氯生对NADH呈现竞争性动力学,在零NADH和饱和NAD(+) 条件下,抑制常数为38 pM。当改变NAD(+) 时观察到非竞争性动力学,在饱和NAD(+) 条件下,抑制常数为22 pM。通过跟踪预先与三氯生和NAD(+) 孵育的EACPR稀释后催化活性的恢复情况,测得抑制剂解离速率常数(k(off))为1.9×10(-4) s(-1)。通过监测添加EACPR开始的测定过程中抑制的起始情况,估计结合速率常数(k(on))为2.6×10(7) s(-1) M(-)1。正如预期的那样,k(off)/k(on) = 7.1 pM的比值与稳态研究中的抑制常数相似。已确定大肠杆菌EACPR与辅酶和三氯生复合物的晶体结构,分辨率为1.9 Å,表明该化合物与二氮杂硼烷抑制剂结合在相似的位点。三氯生的高亲和力似乎归因于其与催化过程中紧密结合的中间体的结构相似性。